Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease
Authors:
- Johannes WalliJWJohannes Walli
- Ulrike DemelUDUlrike Demel
- Gernot P. TilzGTGernot P. Tilz
- Bernhard WidnerBWBernhard Widner
- Dietmar FuchsDFDietmar Fuchs
- 1 April 1999
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 37 (4) , 429-431
Abstract
We measured serum neopterin concentrations in 24 patients with Alzheimer's disease (8 males, 16 females; age: 73.1 ± 6.2 years; free of any infectious process) and fourteen controls of similar age (4 males, 10 females; age: 69.7 ± 8.8 years). Compared to controls, significantly higher concentrations of neopterin (p < 0.01) were found in patients with Alzheimer's disease. Among patients, concentrations of neopterin were higher in those with lower mini-mental-state (p < 0.05), and an invers correlation existed between mini-mental-state and neopterin concentrations. No such association existed with the duration of the disease. There were also significant correlations between neopterin and serum concentrations of immune activation markers such as soluble tumor necrosis factor (TNF) receptor and soluble interleukin-2 receptor (all p < 0.01). Thus, increased concentrations of neopterin in serum of patients with Alzheimer's disease correlate with the severity of dementia. The data imply a chronic state of peripheral immune activation in Alzheimer's disease.Keywords
This publication has 24 references indexed in Scilit:
- Evaluation of DementiaNew England Journal of Medicine, 1996
- Oxidative damage in neurodegenerative diseaseThe Lancet, 1994
- Serum auto-antibodies in Alzheimer's diseaseActa Neurologica Scandinavica, 1991
- IL-6-mediated events in Alzheimer's disease pathologyImmunology Today, 1991
- Reduced natural killer cell activity in patients with dementia of the Alzheimer typeActa Neurologica Scandinavica, 1991
- Serum levels of tumor necrosis factor alpha, interleukin-1 alpha and beta in healthy elderly subjectsAGE, 1991
- Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's diseaseNeuroscience Letters, 1990
- Changes in brain gene expression shared by scrapie and Alzheimer disease.Proceedings of the National Academy of Sciences, 1989
- On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseasesEuropean Journal of Immunology, 1989
- Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's diseaseCell, 1988